Dasatinib as Front-Line Monotherapy for the Induction Treatment of Adult and Elderly Ph+ Acute Lymphoblastic Leukemia (ALL) Patients: Interim Analysis of the GIMEMA Prospective Study LAL1205.
暂无分享，去创建一个
R. Foà | M. Baccarani | A. Vitale | M. Vignetti | G. Martinelli | G. Cimino | G. Meloni | A. Guarini | M. Luppi | L. Elia | S. Sica | C. Castagnola | R. Nieddu | S. M. D. Propris